Novo Nordisk’s
Ozempic was officially launched in india on
December 12, 2025. The drug has gained attention worldwide for its effectiveness in managing
type-2 diabetes, and while it is marketed as
Wegovy for weight loss in the US and Europe, in india it is
approved specifically for adult patients with type-2 diabetes.Despite its benefits, doctors caution that
Ozempic is not suitable for everyone, and certain individuals should avoid it due to potential side effects or health risks.
Who Should Avoid Ozempic?1.
People With Type-1 Diabeteso Ozempic is specifically approved for
type-2 diabetes, where the body still produces insulin.o Using it in type-1 diabetes may be
ineffective or unsafe, as it does not replace the need for insulin therapy.2.
Individuals With a history of Pancreatitiso Clinical data suggests a
potential risk of pancreatitis in some users.o Patients with
a history of pancreatic inflammation should avoid the drug or use it only under strict medical supervision.3.
People With Medullary Thyroid Carcinoma (MTC) or MEN2o Ozempic carries a
black box warning for those with a personal or family history of
MTC or Multiple Endocrine Neoplasia type 2 (MEN2).o These patients are at increased risk of
thyroid tumors with the use of GLP-1 receptor agonists like Ozempic.4.
Pregnant or Breastfeeding Womeno The drug’s safety has
not been established for pregnancy or lactation.o Alternative diabetes management strategies are recommended for expectant or nursing mothers.5.
Individuals With Severe Gastrointestinal Disorderso Ozempic can cause
nausea, vomiting, or delayed gastric emptying.o Patients with
gastroparesis, chronic nausea, or severe gastrointestinal disease may experience worsening symptoms.
Other Considerations·
Kidney or Liver Impairment: Dose adjustments may be required, and in some cases, the drug may be avoided.·
Drug Interactions: Patients on
other medications for diabetes, cardiovascular disease, or obesity should consult their doctor before starting Ozempic.·
Monitoring Required: Regular check-ups are recommended to monitor
blood sugar levels, kidney function, and potential side effects.
ConclusionWhile
Ozempic is a powerful tool for managing type-2 diabetes, it is
not for everyone. Patients with
type-1 diabetes, pancreatitis history, thyroid cancer risk, pregnancy, or severe gastrointestinal conditions should avoid it or use it under strict supervision. Consulting a
qualified healthcare professional is essential before starting treatment to ensure both
safety and effectiveness.
Disclaimer:The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of any agency, organization, employer, or company. All information provided is for general informational purposes only. While every effort has been made to ensure accuracy, we make no representations or warranties of any kind, express or implied, about the completeness, reliability, or suitability of the information contained herein. Readers are advised to verify facts and seek professional advice where necessary. Any reliance placed on such information is strictly at the reader’s own risk.